Strong science doesn’t get funded on its own.

Between early discovery and scale, life science companies face the same challenges—complex grant pathways, unclear commercialization strategy, and operations that aren’t built to grow.

Streamline BioOps helps Seed–Series B biotech and medtech companies secure non-dilutive funding and build the systems needed to use it effectively.

We don’t just write grants. We position your science to win—aligning your narrative, validation strategy, and commercialization plan before submission, then supporting execution post-award.

We support:

Grant strategy and proposal development (federal + foundation)
Scientific positioning and study design
Commercialization planning
Lab operations and scale-up
Quality systems and audit readiness

We work with a select number of clients to provide hands-on, high-impact support.

If you’re preparing for funding—or realizing your operations can’t keep up with your ambitions—we should talk.

Streamline BioOps

Org chart

Teams

Offices